For over a decade and as the 1st distributor of the original version of TM-Flow, Bowman Hewitt Solutions has served as the longest-standing TM-Flow System relationship for doctors needing to improve practice profitability while treating patients effectively.
Bowman Hewitt Solutions Connects Doctors with Patient Care Technology & Technical Support
As President & Owner of the company, Bo McCorkle has been on the scene of TM-Flow technology since the days of its original emergence in the medical space. From the days of selling the original ES Complex (1st version of TM-Flow) to its current Version 5 format, Bo is no stranger to the TM-Flow System and all it provides to patient care. Physicians, Practice Administrators, & Medical Sales Reps alike have all come to rely on the technology afforded to patient diagnosis and treatment that the TM-Flow System provides. The primary focus of this system is to identify indicators of Vascular Disease and Autonomic Nervous System (ANS) dysfunction, including but not limited to Type 2 Diabetes precursors. As COVID emerged in early 2020, the medical community knew it became vital to look even more closely at those patients with immunocompromised conditions, so that early diagnoses and potential treatments in tandem with COVID were addressed as early as possible. The TM-Flow System still proved to be a central device with which to achieve these early indicator 'alerts' and allow medical professionals to properly treat patients in conjunction with what it revealed; it continues to be today!
Comentarios